• Korean Journal of Acupuncture
• /
• v.19 no.1
• /
• pp.67-75
• /
• 2002

목적 : 자성(雌性) 흰쥐에서 phenylhydrazine으로 유발된 용혈성 빈혈에 오미자 약침의 항빈혈효과를 알아보기 위해서 적혈구수, hematocrit ratio, hemoglobin, 혈청 철함유량 및 serum total iron binding capacity (TIBC)를 관찰하였다. 방법 : 실험동물은 정상군, 대조군, 250 mg/kg 오미자 투여군 및 500 mg/kg 오미자 투여군으로 총 4개의 군으로 분류하였다. 정상군의 흰쥐는 아무런 처치도 하지 않았고, 대조군은 phenylhydrazine으로 용혈성 빈혈을 유발하였다. 오미자 투여군은 용혈성 빈혈을 유발한 후 7일간 매일 250 mg/kg 및 500 mg/kg의 용량으로 중완혈에 자침하였다. 결과 : 적혈구수, hematocrit ratio 및 hemoglobin은 대조군에서 정상군에 비해 감소한 반면 오미자 투여군은 증가하였다. 혈청 철함유량과 TIBC는 대조군에서 증가하였으나, 오미자 투여군에서는 감소하였다. 이러한 결과로 중완혈에 오미자 자침은 phenylhydrazine으로 유발된 용혈성 빈혈에서 항빈혈효과가 있는 것으로 사려된다.

• The Korean Journal of Zoology
• /
• v.6 no.2
• /
• pp.1-5
• /
• 1963

SM계인 마우스 ♂♀를 정상군과 4개의 실험군, 즉 온열적 (33 $^{\circ}C$-60분, 매일 각각 폭로) 및 한냉적인 (5$^{\circ}C$-60분과 $0^{\circ}C$-60분, 매일 각각 폭로) 군으로 나누어 최소한 22일간 순화시킨 후 여지 전기영동에 의해서 Albumin /blobulin 비와 단백질 분할을 측정하고 또한 혈청전단백질량, 혈색소량, Hematocrit 비, 적혈구 포약성 및 간장 신장기관중량을 측정하였다. A/G 비와 전단백질양은 온열적 증가와 한랭적 증가의 각군이 정상군보다 유의하게 현저히 낮은 치를 나타내고 있다. 간장중량, 혈색소량 및 Hematocrit 비는 정상군보다 온열적 한랭적 조건하에서 낮은 치를 또한 나타내고 있다. 그러나 신장중량은 현저하게 증가된 치를 나타내고 있다. 온열적 한냉적 조건군의 간장에서의 조직학적 소견은 현저한 변화는 없고 다만 혈관적 변화만 나타내고 적혈구의 포약성은 거의 변화가 없다. 이와 같은 결과로 미루어 보다 온열적 한랭적의 효과로 인해서 주로 간장기능 즉 단백질대사에 이상을 초래하는 것으로 생각된다.

• The Korean Journal of Zoology
• /
• v.6 no.2
• /
• pp.6-10
• /
• 1963

가물치( Ophicephalus argus CANTOR) 2 년생(168$\pm$4g)107마리를 대조군과 실험적으로 나누고 실험군에는 일시에 2.9mg/kg 체동의 potassium cyanide을 배근에 직접 주사하였다. 약물 처리후 시간의 경과에 따라 나타나는 Albumin/Blbulin(A/G)비, 총혈청단백질량, hematocrit 비 및 간장 및 신장의 중량변화를 측정하였다. 약물 처리 직후는 A/G 비 , 총혈청단백질량 및 hematocrit 비는 각각 현저하게 감소되었으나 많은 시간이 경과함에 따라 점차 증가되어 228시간이후는 거의 대조군과 그것과 가까운 결과를 얻었다. 그러나 간장과 신장의 중량은 약물 처리 직후는 오히려 약간 증가되는 상태였으나 , 48시간이후 급히 감소되었다가 점차 역시 대조군과 가까운 결과를 나타냈다. 이상의 결과로서 KCN가 어류의 호흡 억제작용뿐만 아니라 단백질대사에도 영향을 미치는 것으로 생각된다.

• Proceedings of the Korean Society of Applied Pharmacology
• /
• 1996.04a
• /
• pp.244-244
• /
• 1996

In previous studies we reported that the levels of RBC, hemoglobulin and hematocrit in SAM Rl and SAM P6 were increased significantly from 7 day after oral administration of the pilose antler extract, 5g/kg/day, and were lasted during the study. Therefore, this study was performed to elucidate mechanism of erythropoietic action by the extract administration. SAM Rl and SAM P6 were chosen as experimental animals. At age of 12 weeks, pilose antler extract were given 0.3 and 5 g/kg/day (p.o.) each for 0, 7 and 14 days in both animals. Complete blood cells (CBC) such as WBC, lymphocytes, monocytes, granulocytes, RBC, hemoglobulin, and hematocrit were counted. And plasma concentration of erythropoietin (EPO) which is the major regulator of erythropoiesis was measured using $\^$125/I-antierythropoietin IgG. Ferritin concentration in plasma was also analyzed.

• Korean Journal of Agricultural Science
• /
• v.50 no.2
• /
• pp.155-164
• /
• 2023

A total of 16 sows (average parity = 3.5 ± 0.10, standard deviation = 2.05) and their newborn pigs (Duroc × [Landrace × Yorkshire], initial body weight 1.53 ± 0.07 kg) were used in a 21-day study. On day 3 of age, piglets along with their dam were divided into two groups: CON and TRT. CON group piglets did not receive any iron injection while, TRT group piglets received 200 mg of injectable iron (GleptoForte) in a single dose. The administration of iron at day-3 of birth improved weaning body weight and overall average daily gain in sucking piglets compared with their control counterparts. For blood criteria, injection of 200 mg of iron improved serum iron values and hematocrit and decreased total iron binding capacity (TIBC) during the day 21 period. In summary, 200 mg iron injection at birth resulted in greater growth performance and blood iron status. These results indicate that providing 200 mg of injectable iron is sufficient to optimize the growth performance and blood iron status of suckling piglets.

• 산업보건소식
• /
• no.21
• /
• pp.18-24
• /
• 1985

A study on the hemoglobin and hematocrit concentrations of the lead exposed workers and organic solvent exposed workers in the Masan Free Export Zone

• Journal of Haehwa Medicine
• /
• v.12 no.2
• /
• pp.1-9
• /
• 2004

1. Purpose Stroke is the most frequent cause of mortality and morbidity rate in Korea with coronary heart disease and cancer. The ischemic type of stroke is increasing tendency. The purpose of this studies is to examine the hematologic difference between cb infarction patients and Korean normal adults. 2. Method The study group consisted of neurologically confirmd 50 cb-infarction patients as the case group and 278 patients as control group that they had no significant result by CT through early examination of stroke in Cheonan oriental hospital of Daejeon university. We tested and compared RBC, hemoglobin, hematocrit, WBC, PT, PTT, total protein, albumin, total bilirubin, direct bilirubin, GOT GPT, $\gamma$-GTP, total cholesterol, triglyceride, HDL-C, glucose, BUN, creatinine, Na, K in the both group. 3. Result In the sample group(cb infarction group), there were many patients with low RBC count but no significant and with low hemoglobin, hematocrit(p<0.05). Thereas, increased WBC count and delayed PTT were showed respectively 20%, 36% in patient group, 7.9%, 4.7% in normal group(p<0.05). Comparing the LFT between cb infarction patients and normal adults, we founded significant cases with low HDL-C level, high glucose level, low potassium level in patient group(p<0.05). But the percentage of high total cholesterol level and triglyceride level were 18%, 29%(norma1 group), 20%, 28%(cb infarction group) respectively, there were no significant difference. 4. Conclusion In this study, we demonstrated that low HDL-C level and high glucose level is one of important risk factor of cb infarction. Also prospective studies are needed to evaluate many risk factor(hemoglobin, hematocrit, WBC, cholesterol, triglyceride, K, etc) of cb infarction.

• Korean Journal of Animal Reproduction
• /
• v.27 no.4
• /
• pp.317-324
• /
• 2003

The present study were performed to analysis the hematocrit and the red blood cells content into the blood plasma of the transgenic pigs harboring recombinent human erythropoietin gene (rhEPO). Mouse whey acidic protein (mWAP) linked to rhEPO gene was microinjected into pronuclei of porcine one-cell zygotes. After delivered of offspring, PCR analyses identified one mWAP-rhEPO transgenic founder offspring(F$_{0}$). The first generation of transgenic pig (F$_{0}$) harboring mWAP-hEPO appeared to be a male, and the second generation (F$_1$) pigs were made by natural mating of F$_{0}$ with domestic swine, and male and female transgenic pigs (F$_1$) were identified by PCR. The blood samples from transgenic and normal pigs were collected for 50 days during lactation and were counted the red blood cell (RBC) numbers and Hematocrit (HCT) content into the blood. The transgenic pigs expressing rhEPO in their blood gave rise to higher RBC numbers and HCT contents than control animals. rhEPO was secreted both in the blood and milk of genetically engineered pigs harboring rhEPO gene. Therefore, this study provides a model regarding the production of transgenic pig carrying hEPO transgene for biomedical research.earch.

• Environmental Analysis Health and Toxicology
• /
• v.4 no.3_4
• /
• pp.7-14
• /
• 1989

Amygdalin has been used for a long time as an anticancer agent. But because of its toxicity, it is difficult to administer continuously for treatment of cancer. This paper was attempted to reduce the side effect and toxicity of amygdalin. That is, effects of cysteine and streptomycin on the toxicity of amygdalin were investigated in rats orally administered amygdalin. 1. The group administered only amygdalin 400 mg/kg was effected on the lung and body weight, hematocrit, hemoglobin, clotting time, SGOT and albumin value. That is, lung and body weight, hematocrit hemoglobin and albumin value were significantly decreased. SGOT and clotting time were significantly increased compared with those of normal group. 2. Weight of lung was significantly increased in the C group (administred amygdalin 400 mg/kg and cysteine 300 mg/kg), D group (amygdalin 400 mg/kg and streptomycin 10 mg/kg), E group (amygdalin 400 mg/kg, streptomycin 10 mg/kg and cysteine 200 mg/kg)and F group (amygdalin 400 mg/kg, streptomycin 10 mg/kg and cysteine 300 mg/kg). 3. Values of hematocrit and hemoglobin were significantly increased, and clotting time was significantly decreased, in the I group and F group compared with those of A group. 4. SGOT was significantly decreased in the C group, E group and F group compared with that of A group. 5. The blood cyanide concentration was significantly decreased in the E group and F group compared with that fo A group. 6. In short, coadministration of cysteine and streptomycin are considered to reduce the toxicity of amygdalin in rats orally administered.

• Journal of Nutrition and Health
• /
• v.32 no.7
• /
• pp.793-801
• /
• 1999

The purposes of this study are to assess iron status in mothers and their newborn infants at birth and to analyze the influence of maternal iron status on their newborn babies. Venous bloods samples were drawn from 144 pregnant women just before delivery and cord bloods of their newborn babies were collected immediately after birth for measurement of hemoglobin, hematocrit, serum iron, ferritin, total binding capacity and transferrin saturation. The values of hemoglobin and hematocrit were significantly lower in the mothers(10.9$\pm$1.43g/dl and 33.7$\pm$3.67%) than in their newborn infants(14.7$\pm$1.43g/dl and 45.3$\pm$4.76%)(p<0.0001). At delivery, serum iron levels in cord blood were about twice as high as those in the maternal blood, and serum ferritin levels in the cord blood were about four times higher than those in the maternal blood. The serum ferritin levels of multigravidas were higher than those of primigravidas,. but there was no difference between the serum ferritin levels of their infants. The serum ferritin levels of the mothers and their infants were higher in maternal group with iron supplement regularly than in other maternal group without iron supplement during pregnancy. Among the mothers, 26.4% had a serum ferritin levels below 12ng/ml(i.e. depleted iron stores)and 78.9% had a hemoglobin below 12g/dl(i.e.iron deficient anemia). When the maternal group was classified according to their serum ferritin levels by 9ng/ml, 12ng/dl or 20ng/ml, there was no significant difference in the iron status of their newborn infants among the three groups. The hemoglobin and serum ferritin levels of the mothers were well correlated with those of their babies. The maternal hemoglobin values negatively correlated with infant birth weight. It is possible that the demands of iron of the mother might be increased in the case of a newborn infant of greater size. The results of this study provide useful information regarding establishment of RDA for iron in pregnant women and guidance about the need for iron supplement during pregnancy.